Jason Hsu

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
3 years
Director since
2023

3 years of board service in total across 1 board, counting each seat separately. Longest: Immix Biopharma Inc., 3 years.

3 years ยท Since 2023

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Dec 23, 2024 Immix Biopharma Inc. Open-market purchase +40,000 $2.19 $87,600
Dec 20, 2024 Immix Biopharma Inc. Open-market purchase +7,700 $2.17 $16,709
Aug 22, 2024 Immix Biopharma Inc. Open-market purchase +8,100 $2.25 $18,225
Aug 21, 2024 Immix Biopharma Inc. Open-market purchase +15,000 $2.23 $33,450
Jul 24, 2024 Immix Biopharma Inc. Open-market purchase +6,000 $2.15 $12,900
Jul 18, 2024 Immix Biopharma Inc. Open-market purchase +3,200 $2.07 $6,624
Dec 11, 2023 Immix Biopharma Inc. Open-market purchase +31,000 $4.67 $144,770
Dec 8, 2023 Immix Biopharma Inc. Open-market purchase +25,000 $4.88 $122,000
Sep 15, 2023 Immix Biopharma Inc. Open-market purchase +7,000 $2.49 $17,430
Sep 14, 2023 Immix Biopharma Inc. Open-market purchase +10,000 $2.58 $25,800
Sep 12, 2023 Immix Biopharma Inc. Open-market purchase +30,000 $2.83 $84,900
Sep 11, 2023 Immix Biopharma Inc. Open-market purchase +25,000 $2.89 $72,250
Sep 8, 2023 Immix Biopharma Inc. Open-market purchase +10,000 $2.53 $25,300

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.